Dr Fujiwara on the FDA Approval of Tisotumab Vedotin for Recurrent Cervical Cancer : vimarsana.com

Keiichi Fujiwara, MD, PhD, discusses the significance of the FDA approval of tisotumab vedotin for patients with recurrent or metastatic cervical cancer.

Related Keywords

, Keiichi Fujiwara , Saitama Medical University International Center , D , Hd , Fda Approval Of Tisotumab Vedotin , Patients With Recurrent Or Metastatic Cervical Cancer ,